Plasmablastic lymphoma: a case report
DOI:
https://doi.org/10.17159/sadj.v79i04.16793Keywords:
Epstein Barr Virus, Plasmablastic lymphoma, Lymphoma, Virus oncogenic potentialAbstract
A male patient presented at the University of Witwatersrand with a rapidly growing mass on the palate extending across to the buccal aspect. The growth had a history of three months and presented with symptoms of pain together with spontaneous bleeding. Examination revealed that the patient was a smoker and tested seropositive for HIV despite being unaware of the condition.
Radiographic bone loss is evident on a panoramic radiograph and clinically corelated by grade three mobility of involved teeth. The biopsy revealed a definitive diagnosis of plasmablastic lymphoma which is linked to oncogenesis potential of Epstein Barr virus. Presented in this paper is a case study of an HIV positive male who developed plasmablastic lymphoma.
Downloads
References
Escalante, G. M., Mutsvunguma, L. Z., Muniraju, M., Rodriguez, E., & Ogembo, J. G. (2022). Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective. Frontiers in Immunology, 13, 867918. https://doi.org/10.3389/fimmu.2022.867918
Heawchaiyaphum, C., Iizasa, H., Ekalaksananan, T., Burassakarn, A., Kiyono, T., Kanehiro, Y., Yoshiyama, H., & Pientong, C. (2020). Epstein–Barr Virus Infection of Oral Squamous Cells. Microorganisms, 8(3), 419. https://doi.org/10.3390/microorganisms8030419
Lezzoni, J. C., Gaffey, M. J., & Weiss, L. M. (1995). The Role of Epstein-Barr Virus in Lymphoepithelioma-like Carcinomas. American Journal of Clinical Pathology, 103(3), 308–315. https://doi.org/10.1093/ajcp/103.3.308
Niedobitek, G., Agathanggelou, A., Herbst, H., Whitehead, L., Wright, D. H., & Young, L. S. (1997). EPSTEIN-BARR VIRUS (EBV) INFECTION IN INFECTIOUS MONONUCLEOSIS: VIRUS LATENCY, REPLICATION AND PHENOTYPE OF EBV-INFECTED CELLS. The Journal of Pathology, 182(2), 151–159. https://doi.org/10.1002/(SICI)1096-9896(199706)182:2<151:AID-ATH824>3.0.CO;2-3
Bu, G.-L., Xie, C., Kang, Y.-F., Zeng, M.-S., & Sun, C. (2022). How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection. Viruses, 14(11), 2372. https://doi.org/10.3390/v14112372
Amon, W., & Farrell, P. J. (2005). Reactivation of Epstein-Barr virus from latency. Reviews in Medical Virology, 15(3), 149–156. https://doi.org/10.1002/rmv.456
Slots, J., Saygun, I., Sabeti, M., & Kubar, A. (2006). Epstein–Barr virus in oral diseases. Journal of Periodontal Research, 41(4), 235–244. https://doi.org/10.1111/j.1600-0765.2006.00865.x
Singh, D. R., Nelson, S. E., Pawelski, A. S., Cantres-Velez, J. A., Kansra, A. S., Pauly, N. P., Bristol, J. A., Hayes, M., Ohashi, M., Casco, A., Lee, D., Fogarty, S. A., Lambert, P. F., Johannsen, E. C., & Kenney, S. C. (2022). Type 1 and Type 2 Epstein Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase immortalized normal oral keratinocytes. PLoS Pathogens, 18(10), e1010868.
https://doi.org/10.1371/journal.ppat.1010868
Guidry, J., Birdwell, C., & Scott, R. (2018). Epstein–Barr virus in the pathogenesis of oral cancers. Oral Diseases, 24(4), 497–508. https://doi.org/10.1111/odi.12656
Lupo, J., Truffot, A., Andreani, J., Habib, M., Epaulard, O., Morand, P., & Germi, R. (2023). Virological Markers in Epstein–Barr Virus-Associated Diseases. Viruses, 15(3), 656. https://doi.org/10.3390/v15030656
Rezk, S. A., & Weiss, L. M. (2019). EBV–Associated Lymphoproliferative Disorders. Surgical Pathology Clinics, 12(3), 745–770. https://doi.org/10.1016/j.path.2019.03.002
Hue, S. S.-S., Oon, M. L., Wang, S., Tan, S.-Y., & Ng, S.-B. (2020). Epstein–Barr virus-associated T- and NK-cell lymphoproliferative diseases: An update and diagnostic approach. Pathology, 52(1), 111–127. https://doi.org/10.1016/j.pathol.2019.09.011
Smith, N. A., Coleman, C. B., Gewurz, B. E., & Rochford, R. (2020). CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells. Journal of Virology, 94(11), e00428-20. https://doi.org/10.1128/JVI.00428-20
Leight, E. R., & Sugden, B. (2000). EBNA-1: A protein pivotal to latent infection by Epstein–Barr virus. Reviews in Medical Virology, 10(2), 83–100. https://doi.org/10.1002/(SICI)1099-1654(200003/04)10:2<83::AID-RMV262>3.0.CO;2-T
Allday, M. j., Sinclair, A., Parker, G., Crawford, D. h., & Farrell, P. j. (1995). Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. The EMBO Journal, 14(7), 1382–1391. https://doi.org/10.1002/j.1460-2075.1995.
tb07124.x
Leucci, E., Cocco, M., Onnis, A., De Falco, G., van Cleef, P., Bellan, C., van Rijk, A., Nyagol, J., Byakika, B., Lazzi, S., Tosi, P., van Krieken, H., & Leoncini, L. (2008). MYC translocation-negative classical Burkitt lymphoma cases: An alternative pathogenetic mechanism involving miRNA deregulation. The Journal of Pathology, 216(4), 440–450. https://doi.org/10.1002/path.2410
Porter, S. R., Dios, P. D., Kumar, N., Stock, C., Barrett, A. W., & Scully, C. (1999). Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 87(6), 730–734. https://doi.org/10.1016/S1079-2104(99)70170-8
Meer, S., Perner, Y., McAlpine, E. D., & Willem, P. (2020). Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area. Histopathology, 76(2), 212–221. https://doi.org/10.1111/his.13964
Rezk, S. A., & Weiss, L. M. (2019). EBV–Associated Lymphoproliferative Disorders. Surgical Pathology Clinics, 12(3), 745–770. https://doi.org/10.1016/j.path.2019.03.002
Escalante, G. M., Mutsvunguma, L. Z., Muniraju, M., Rodriguez, E., & Ogembo, J. G. (2022). Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective. Frontiers in Immunology, 13, 867918. https://doi.org/10.3389/fimmu.2022.867918
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
.png){kind=spacer}